Last Man Standing

Can Giorgio Armani, at 84, turn around a legendary company founded on a style he turned classic?

Ant Financial Is Too Big To Ignore

The Chinese fintech powerhouse scares banks but wants to make them customers

Funds That Lock Up Your Money—On Purpose

Interval funds make withdrawals harder so they can make wilder investments.

Canada's Got A Guy

Bruce Linton is having a great time running Canopy, the biggest pot company in the world. (No, he doesn’t use his product—and he’d prefer you call it cannabis).

Huawei Mobilizes Its Troops

China’s biggest tech company is preparing for a long, drawn-out fight as American supply dries up

How To Freeze Your Salary

Anti-discrimination laws haven’t relieved the relentless pressure to devote more hours to the office.

What's A Global Economy Between Friends?

Trump and Xi have turned this year’s G-20 into a high-stakes showdown.

The Great Model Train Robbery

How did thieves steal a valuable collection of scaled-down locomotives from a train club? Why did the case go cold? And who is “Jamie”?

To Beat The SEC, Run Out The Clock

Money manager Charles Kokesh was supposed to pay back tens of millions of dollars in unlawful gains. But it turns out the watchdog caught him too late.

3G Capital Gets Indigestion

The investment firm’s mashup of Kraft and Heinz just took a $15.4 billion hit.

chuck's new cheddar

a card payment system at chuck e. cheese’s might cause fluctuation in the token-collector market.

Coal Baron. Ex-Con. Senator?

In West Virginia, Don Blankenship’s bid for the Senate is more personal than political

Thelma Golden

The director of Harlem’s Studio Museum is as sharp a fundraiser as she is a curator.

Amaro Goes American

The U.S. cocktail market is changing for the bitter

Under Fire And Losing Trust

Facebook’s attempt to play the victim isn’t shifting attention from its product problems

Why Spotify Is Not The Next Netflix

The company can’t scale its way to success

This Robot Can Detect Lung Cancer

This Robot Can Detect Lung Cancer

The Difficulties Of Cloning A CEO

Teva Pharmaceutical is a generic manufacturer with a particular problem: It can’t find a leader or a strategy—at least not in Israel.

Made To Be Undone

At the Museum of Modern Art’s fashion exhibition opening in October, a reconsideration of the humble zipper. 

K-Pop Eyes Its 'Michael Jackson Moment'

South Korea’s brand of pop music has found fans in the U.S. and China.

3M's Biggest Deal Won't Be A Cure-All

Industrial conglomerate 3M Co. agreed in May to acquire surgical wound-care company Acelity Inc. for $6.7 billion in a deal set to close later this year.

A Lot To Shoulder

Greece’s new prime minister must move quickly to capitalize on investors’ goodwill.

Elizabeth Warren Is Done Playing It Safe

After a slow start, the presidential candidate is gaining momentum by pushing her party to embrace bold, left-wing ideas that could beat Trump at his own game— or cost Democrats everything.

Chasing A New Pack

Women-only motorcycle rallies are gaining speed—and anxious bike makers are finally on their heels.

Low Rates Changed Everything

A decade of cheap money has unmoored the financial world from all the old assumptions.

The NRA Is Hobbled But Don't Expect Tougher Gun Laws

The gun-rights group is hobbled by lawsuits and has lost its longtime power brokers.

Like The Odyssey, But For Drones

A startup’s robot sailboat just returned from Antarctica with some troubling climate clues.

A 3,100-Acre Fixer-Upper

Waterfront Brownfield w/ Rail, Port, ~Near Highway!~ *Bonus* Proximity to 1/3 of US Population! $72 million (Baltimore County)

If The Student Loans Don't Break You, The Rent Will

Luxury developers are driving up housing costs around public university campuses

Wide-Open Lonely Spaces

In all of eastern Montana, the state with America’s highest suicide rate, there’s exactly one practitioner. Rural America has a mental health care crisis